News

June 5, 2007 - Siemens Medical Solutions Molecular Imaging division demonstrated three new syngo software packages ...

Home June 04, 2007
Home
News

June 4, 2007 — Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The stents will degrade within four months and achieve the same results as conventional stents, conclude authors of an article published in this week's edition of The Lancet.

Home June 03, 2007
Home
News

June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.

Home June 03, 2007
Home
News

June 4, 2007 — A new radiological test, used to detect acute coronary trauma has the ability to save valuable time and ...

Home June 03, 2007
Home
News

June 1, 2007 — Siemens recently announced the introduction of Syngo DynaCT Cardiac, which provides three-dimensional ...

Home May 31, 2007
Home
News

June 1, 2007 — New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation ...

Home May 31, 2007
Home
News

June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.

Home May 31, 2007
Home
News

June 1, 2007 —ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was ...

Home May 31, 2007
Home
News

May 31 -- Cardiac Science Corp. announced today it has entered into a two-year marketing partnership with the City of ...

Home May 30, 2007
Home
News

May 31, 2007 — MediNotes Corporation, a leading provider of best-of-breed electronic medical record solutions for small ...

Home May 30, 2007
Home
News

May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the deadliest kind of heart attack: an ST-elevation myocardial infarction (STEMI). The total blockage of a coronary artery is fatal unless treated quickly — within 30 minutes for clot-dissolving drug treatment, and within 90 minutes for angioplasty.

Home May 30, 2007
Home
News

May 30, 2007 -- The Channel Group, LLC announced today that it has formed Lesanne Life Sciences, LLC, a medical ...

Home May 29, 2007
Home
News

May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent ...

Home May 29, 2007
Home
News

May 30, 2007 -- Daxor Corp., a medical instrumentation and biotechnology company, announced the June 2007 publication of ...

Home May 29, 2007
Home
News

May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m. to noon, EDT.

Home May 29, 2007
Home
Subscribe Now